[1] Garcia-Montoya L, Gul H, Emery P. Recent advances in ankylosing spondylitis: understanding the disease and management. F1000Research. 7,1512 (2018)
[2] Ward MM, Deodhar A, Gensler LS, Dubreuil M. 2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic .Axial Spondyloarthritis. 71,1599-613. (2019)
[3] Haibel H, Brandt HC, Song IH, Brandt A, Listing J, Rudwaleit M, et al. No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trial. Annals of the rheumatic diseases.66,419-21 (2007)
[4] Ma Z, Liu X, Xu X, Jiang J, Zhou J, Wang J, et al. Safety of tumor necrosis factor-alpha inhibitors for treatment of ankylosing spondylitis. Medicine.96,e7145(2017)
[5] Zhu W, He X, Cheng K, Zhang L, Chen D, Wang X, et al. Ankylosing spondylitis: etiology, pathogenesis, and treatments. Bone research.7, 22 (2019)
[6] Nie J, Li YY, Zheng SG, Tsun A, Li B. FOXP3(+) Treg Cells and Gender Bias in Autoimmune Diseases. Frontiers in immunology. 6,493 (2015)
[7] Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25).
Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. Journal of immunology (Baltimore, Md : 1950). 155,1151-64(1995)
[8] Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nature immunology. 4,330-6(2003)
[9] Kmieciak M, Gowda M, Graham L, Godder K, Bear HD, Marincola FM, et al. Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function. Journal of Translational Medicine. 7,89 (2009)
[10] Liu W, Putnam AL, Xu-yu Z, Szot GL, Lee MR, Zhu S, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. Journal of Experimental Medicine. 203,1701-11(2006)
[11] Analay Y, Ozcan E, Karan A, Diracoglu D, Aydin R. The effectiveness of intensive group exercise on patients with ankylosing spondylitis. Clinical rehabilitation. 17,631-6(2003)
[12] Karatay S, Yildirim K, Melikoglu MA, Akcay F, Şenel K. Effects of dynamic exercise on circulating IGF-1 and IGFBP-3 levels in patients with rheumatoid arthritis or ankylosing spondylitis. Clinical rheumatology.26,1635-9(2007)
[13] Matheny RW, Jr., Nindl BC, Adamo ML. Minireview: Mechano-growth factor: a putative product of IGF-I gene expression involved in tissue repair and regeneration. Endocrinology. 151,865-75(2010)
[14] Yang SY, Goldspink G. Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in myoblast proliferation and differentiation. FEBS letters. 522,156-60(2002)
[15] Bilbao D, Luciani L, Johannesson B, Piszczek A, Rosenthal N. Insulin‐like growth factor‐1 stimulates regulatory T cells and suppresses autoimmune disease. EMBO Molecular Medicine.6,1423-35(2014)
[16] Tran TM, Dorris ML, Satumtira N, Richardson JA, Hammer RE, Shang J, et al. Additional human beta2-microglobulin curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA-B27-transgenic rats. Arthritis and rheumatism. 54,1317-27(2006)
[17] Taurog JD, Rival C, van Duivenvoorde LM, Satumtira N, Dorris ML, Sun M, et al. Autoimmune epididymoorchitis is essential to the pathogenesis of male-specific spondylarthritis in HLA-B27-transgenic rats. Arthritis and rheumatism.
8,2518-28(2012)
[18] van Tok MN, Satumtira N, Dorris M, Pots D, Slobodin G, van de Sande MG, et al. Innate Immune Activation Can Trigger Experimental Spondyloarthritis in HLA-B27/Hubeta2m Transgenic Rats. Frontiers in immunology. 8,920(2017)
[19] Waynforth H, Flecknell P. Experimental and Surgical Technique in the Rat. 2. London: Academic Press. 275–276(1992)
[20] van Duivenvoorde LM, Dorris ML, Satumtira N, van Tok MN, Redlich K, Tak PP, et al. Relationship between inflammation, bone destruction, and osteoproliferation in the HLA-B27/human β2 -microglobulin-transgenic rat model of spondylarthritis. Arthritis and rheumatism.10,3210-9(2012)
[21] Benedek TG. How did ankylosing spondylitis become a separate disease? Clinical and experimental rheumatology.4,S3-9(2009)
[22] Brown MA, Laval SH, Brophy S, Calin A. Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Annals of the rheumatic diseases.11,883-6(2000)
[23] Bobacz K, Ullrich R, Amoyo L, Erlacher L, Smolen JS, Graninger WB. Stimulatory effects of distinct members of the bone morphogenetic protein family on ligament fibroblasts. Annals of the rheumatic diseases.2,169-77(2006)
[24] Inanc B, Elcin AE, Elcin YM. Osteogenic induction of human periodontal ligament fibroblasts under two- and three-dimensional culture conditions. Tissue engineering. 12,257-66(2006)
[25] Waksman BH, Pearson CM, Sharp JT. Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant. II. Evidence that the disease is a disseminated immunologic response to exogenous antigen. J Immunol85,403–17(1960)
[26] Shevach EM. Foxp3(+) T Regulatory Cells: Still Many Unanswered Questions-A Perspective After 20 Years of Study. Frontiers in immunology. 9,1048(2018)
[27] Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nature immunology.4,330-6(2003)
[28] Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nature genetics. 27,20-1(2001)
[29] Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nature genetics.;27,68-73(2001)
[30] Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science (New York, NY).299,1057-61(2003)
[31] Liu W, Putnam AL, Xu-yu Z, Szot GL, Lee MR, Zhu S, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. Journal of Experimental Medicine. 203,1701-11(2006)
[32] Wang C, Yu X, Yan Y, Yang W, Zhang S, Xiang Y, et al. Tumor necrosis factor-α: a key contributor to intervertebral disc degeneration. Acta biochimica et biophysica Sinica. 49,1-13(2017)
[33] Saha P, Smith A. TNF-α (Tumor Necrosis Factor-α). Arteriosclerosis, thrombosis, and vascular biology.38,2542-3(2018)
[34] Gaffen SL, Liu KD. Overview of interleukin-2 function, production and clinical applications. Cytokine.28,109-23(2004)
[35] Malek TR, Yu A, Vincek V, Scibelli P, Kong L. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity.17,167-78(2002)
[36] Malek TR, Porter BO, Codias EK, Scibelli P, Yu A. Normal lymphoid homeostasis and lack of lethal autoimmunity in mice containing mature T cells with severely impaired IL-2 receptors. Journal of immunology (Baltimore, Md : 1950). 164,2905-14(2000)
[37] Tian G, Li JL, Wang DG, Zhou D. Targeting IL-10 in auto-immune diseases. Cell biochemistry and biophysics. 70,37-49(2014)